Murali Doraiswamy

P. Murali Doraiswamy
EducationUniversity of Madras
Known forprecision medicine, Artificial intelligence in healthcare, Molecular diagnostics, Alzheimer's research
Notable workThe Alzheimer's Action Plan
AwardsFellow of the Royal College of Physicians (London)
Scientific career
Fieldsprecision medicine, neuroscience, mental health
WorkplacesDuke University School of Medicine

P. Murali Doraiswamy is an Indian physician-scientist, professor in psychiatry, neurology and medicine at Duke University School of Medicine.[1][2] His work focuses on the fields of precision medicine, healthy aging, and clinical applications of AI.[3][4] Doraiswamy has contributed to the clinical development of drugs, devices and diagnostics that are in wide use in clinical medicine.[1][5] He has authored over 400 publications and co-authored the book The Alzheimer's Action Plan.[6][7]

Early life and education

Doraiswamy earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Madras, India. After completing his medical education, he pursued residency training at Duke University, where he has continued his continued his career in neuroscience and clinical research.

Career

Doraiswamy serves as a professor in the Departments of Psychiatry, Neurology, and Medicine at Duke University School of Medicine. He is the director of the Neurocognitive Disorders Program and holds affiliations with the Duke-UNC Alzheimer’s Disease Research Center, Duke Center for the Study of Aging[8], the Duke Center for Applied Genomics and Precision Medicine, and the Duke Institute for Brain Sciences, and the Duke Microbiome Center.[9][10] Doraiswamy was a visiting professor at the MIT Media Lab with the Affective Computing Research Group. [11]

Doraiswamy has also served as an advisor to institutions including the National Institutes of Health (NIH),[12] the Food and Drug Administration (FDA),[13] the World Health Organization (WHO), and the World Economic Forum (WEF).[14][15] He has chaired panels on brain research and innovation in mental health care.[16] He has given expert testimony on suicide prevention at the US Sentate Committee on Armed Forces. [17]

Doraiswamy served on the Board of Directors of Baycrest Health System, including Baycrest Hospital and the Rotman Research Institute, and was Co-Chair of the Innovation Advisory Council for the Centre for Aging + Brain Health Innovation (CABHI).[18] He serves on the Board of Trustees of the Live Love Laugh Foundation, a leading NGO focused on rural mental health. [19]

Research and publications

His research centers on neurocognitive disorders, brain health, and the role of artificial intelligence in medicine, human performance and wellbeing. At Duke University, he leads a clinical trials unit that has contributed to the development of diagnostic tests, digital biomarkers, and treatments for multiple neurological, psychiatric, and medical conditions. His work has had an impact on Alzheimer's disease care, mental health, and resilience in aging.[1]

Selected works

  • The Alzheimer's Action Plan (co-authored, 2008) – A comprehensive guide for patients and caregivers dealing with Alzheimer's disease.[6]
  • Empowering 8 Billion minds [20]
  • Deep learning-aided decision support for diagnosis of skin disease across skin tones | Nature Medicine [21]
  • Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs - NAM [22]
  • Harnessing artificial intelligence to transform Alzheimer’s disease research | Nature Medicine [23]
  • Digital cognitive twins in mental health | Nature Mental Health [24]
  • AI Is Revolutionizing Health Care. But It Can’t Replace Your Doctor [25]
  • "Artificial Intelligence and the Future of Psychiatry: Insights from a Global Physician Survey" (2019) – A study on the integration of Artificial intelligence in mental health care.[26]
  • "Neuroimaging Assessment of Early and Late Neurobiological Sequelae of Traumatic brain injury" (2015) – Research on brain injury and its potential link to Chronic traumatic encephalopathy (CTE).[27]
  • Multiple peer-reviewed articles on cognitive disorders, neuroplasticity, and digital health interventions.

Public engagement and media

Doraiswamy's research has been featured in major media outlets, including The New York Times, TIME Magazine,[28] Scientific American,[29] The Wall Street Journal,[30] and BBC News.[31] He has appeared on television programs such as CBS Evening News,[32] NPR,[33] and The Dr. Oz Show.

Awards and honors

See also

References

  1. 1 2 3 "P. Murali Doraiswamy | Duke University School of Medicine". medschool.duke.edu. Retrieved 2025-02-08.
  2. ↑ "P. Murali Doraiswamy | Scholars@Duke profile". scholars.duke.edu. Retrieved 2026-07-09.
  3. ↑ "P. Murali Doraiswamy | Duke Department of Psychiatry & Behavioral Sciences". psychiatry.duke.edu. Retrieved 2025-02-08.
  4. ↑ Times, The New York (2012-11-16). "Answers About Alzheimer's, Part 2". The New York Times. ISSN 0362-4331. Retrieved 2026-07-09.
  5. ↑ "A 'Once in a Lifetime' Opportunity to Improve Mental Health Care". Duke University School of Medicine. 2021-10-27. Retrieved 2026-07-09.
  6. 1 2 "P Murali Doraiswamy M D > Compare Discount Book Prices & Save up to 90% > ISBNS.net". www.isbns.net. Retrieved 2025-02-08.
  7. ↑ "The Brain Forum". thebrainforum.org. Retrieved 2026-07-09.
  8. ↑ "Aging Center Senior Fellows | Duke Center for the Study of Aging and Human Development". agingcenter.duke.edu. Retrieved 2026-07-20.
  9. ↑ "P. Murali Doraiswamy | Scholars@Duke profile". scholars.duke.edu. Retrieved 2025-02-08.
  10. ↑ Fannon, Dominic (December 2010). "P. Murali Doraiswamy". The Psychiatrist. 34 (12): ibc. doi:10.1192/pb.bp.110.033217. ISSN 1758-3209.
  11. ↑ "Person Overview ‹ Murali Doraiswamy". MIT Media Lab. Retrieved 2026-07-20.
  12. ↑ "Digital Mental Health: Innovating in a Time of High Anxiety - National Institute of Mental Health (NIMH)". www.nimh.nih.gov. 2020-04-13. Retrieved 2025-02-08.
  13. ↑ Kolata, Gina (2013-03-14). "F.D.A. Plans Looser Rules on Approving Alzheimer's Drugs". The New York Times. ISSN 0362-4331. Retrieved 2025-02-08.
  14. ↑ "Doraiswamy named chair of World Economic Forum's Global Agenda Council on Brain Research". Duke University School of Medicine. 2015-10-23. Retrieved 2026-07-20.
  15. ↑ "This is how we can empower 8 billion minds by 2030". World Economic Forum. Archived from the original on 2024-11-11. Retrieved 2025-02-08.
  16. ↑ "A 'Once in a Lifetime' Opportunity to Improve Mental Health Care". Duke University School of Medicine. 2021-10-27. Retrieved 2025-02-08.
  17. ↑ "To receive testimony on suicide prevention and related behavioral health interventions in the Department of Defense | United States Senate Committee on Armed Services". www.armed-services.senate.gov. Retrieved 2026-07-20.
  18. ↑ Impact Report 2016–2017 (PDF) (Report). Centre for Aging + Brain Health Innovation (CABHI), Baycrest. 2017. p. 42. Retrieved 20 July 2026.
  19. ↑ "About us". Live Love Laugh. Retrieved 2026-07-20.
  20. ↑ Doraiswamy, P. Murali; London, Elisha; Varnum, Peter (28 October 2019). Empowering 8 Billion Minds: Enabling Better Mental Health for All via the Ethical Adoption of Technologies (PDF). Nam Perspectives (Report). et al. National Academy of Medicine. doi:10.31478/201910b. Retrieved 20 July 2026.
  21. ↑ Groh, Matthew; Badri, Omar; Daneshjou, Roxana; Koochek, Arash; Harris, Caleb; Soenksen, Luis R.; Doraiswamy, P. Murali; Picard, Rosalind (2024-02-05). "Deep learning-aided decision support for diagnosis of skin disease across skin tones". Nature Medicine. 30 (2): 573–583. doi:10.1038/s41591-023-02728-3. PMC 10878981. PMID 38317019.
  22. ↑ Lee, Peter; Abernethy, Amy; Shaywitz, David; Gundlapalli, Adi V.; Weinstein, Jim; Doraiswamy, P. Murali; Schulman, Kevin; Madhavan, Subha (18 January 2022). Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs (Report). NAM Perspectives. National Academy of Medicine. doi:10.31478/202201c. PMC 8970223. Retrieved 20 July 2026.
  23. ↑ Andrieu, Sandrine; Bateman, Randall J.; Bereczki, Erika; Bose, Niranjan; Brookes, Anthony J.; Doraiswamy, P. Murali (May 2025). "Harnessing artificial intelligence to transform Alzheimer's disease research". Nature Medicine. 31 (5). et al.: 1384–1385. doi:10.1038/s41591-025-03632-8. PMID 40169865. Retrieved 20 July 2026.
  24. ↑ Doraiswamy, P. Murali; Duñabeitia, Jon Andoni; Rodriguez, Carlos; Devanand, Davangere P. (2025-09-04). "Digital cognitive twins in mental health". Nature Mental Health. 3 (10): 1106–1108. doi:10.1038/s44220-025-00482-8. ISSN 2731-6076. PMC 13309166. PMID 42369961.
  25. ↑ Doraiswamy, P. Murali; Benioff, Marc (10 September 2025). "AI Is Revolutionizing Health Care. But It Can't Replace Your Doctor". Time. Retrieved 20 July 2026.
  26. ↑ Doraiswamy, P. Murali; Gwyther, Lisa P.; Adler, Tina (2008). The Alzheimer's action plan: the experts' guide to the best diagnosis and treatment for memory problems. New York: St. Martin's Press. ISBN 978-0-312-35539-5. OCLC 187300206.
  27. ↑ Sundman, Mark; Doraiswamy, P. Murali; Morey, Rajendra (2015-09-24). "Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE". Frontiers in Neuroscience. 9: 334. doi:10.3389/fnins.2015.00334. ISSN 1662-453X. PMC 4585087. PMID 26441507.
  28. ↑ Sifferlin, Alexandra (2013-01-28). "Yoga and the Mind: Can Yoga Reduce Symptoms of Major Psychiatric Disorders?". Time. ISSN 0040-781X. Retrieved 2025-02-08.
  29. ↑ "Stories by P. Murali Doraiswamy". Scientific American. Retrieved 2025-02-08.
  30. ↑ "The Neuroscience Behind Hot-Headed Emails". Wall Street Journal. 2015-03-23. ISSN 0099-9660. Retrieved 2025-02-08.
  31. ↑ "Salsa de curry contra la demencia". BBC News Mundo (in Spanish). 2009-06-04. Retrieved 2025-02-08.
  32. ↑ LaPook, Jonathan (2009-05-13). "New Test Could Reveal Dementia Risk - CBS News". www.cbsnews.com. Retrieved 2025-02-08.
  33. ↑ "Can simple brain quizzes predict who gets a virus?". NPR. Retrieved 2025-02-08.
  34. ↑ "P. Murali Doraiswamy". Cure Alzheimer's Fund. Retrieved 2025-02-08.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.